AnalystsKumaraguru RajaKumaraguru Raja's Stock Forecasts
AnalystsKumaraguru Raja
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4503 out of 4554 analysts
Average Return
-65.04%
Win Rate
0%0 out of 16
Risk vs Reward
Poor
Good
Kumaraguru Raja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
No Ratings AvailableKumaraguru Raja doesn't have any winning ratings in our database | |||||
Kumaraguru Raja Analyst Color
Get additional color on Kumaraguru Raja's coverage of popular stocks
Kumaraguru Raja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adial Pharmaceuticals IncADIL | 2 | Strong Buy | $150.00 | +6,812.44% | Reiterates | 9 months ago |
Genenta Science SpaGNTA | 1 | Strong Buy | $15.00 | +283.04% | Assumes | 10 months ago |
Atyr Pharma IncLIFE | 1 | Strong Buy | $9.00 | N/A | Reinstates | a year ago |
Rain Oncology IncRAIN | 1 | Strong Buy | $21.00 | N/A | Reinstates | a year ago |
Apexigen IncAPGN | 1 | Strong Buy | $15.00 | N/A | Reinstates | a year ago |
Monopar TherapeuticsMNPR | 2 | Strong Buy | $18.00 | N/A | Reinstates | a year ago |
Veru IncVERU | 1 | Strong Buy | $31.00 | N/A | Maintains | 2 years ago |
Dermata Therapeutics IncDRMA | 1 | Strong Buy | $224.00 | N/A | Initiates Coverage On | 3 years ago |
Oncternal Therapeutics IncONCT | 1 | Strong Buy | $320.00 | N/A | Initiates Coverage On | 3 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Strong Buy | $120.00 | N/A | Assumes | 3 years ago |
Nls Pharmaceutics LtdNLSP | 1 | Strong Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Lisata Therapeutics IncLSTA | 1 | Strong Buy | $10.00 | N/A | Maintains | 3 years ago |
Cns Pharmaceuticals IncCNSP | 1 | Strong Buy | $300.00 | N/A | Initiates Coverage On | 3 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $90.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.